Yingli Wu

4.3k total citations
145 papers, 3.2k citations indexed

About

Yingli Wu is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Yingli Wu has authored 145 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Molecular Biology, 33 papers in Hematology and 24 papers in Oncology. Recurrent topics in Yingli Wu's work include Ubiquitin and proteasome pathways (36 papers), Retinoids in leukemia and cellular processes (20 papers) and Acute Myeloid Leukemia Research (15 papers). Yingli Wu is often cited by papers focused on Ubiquitin and proteasome pathways (36 papers), Retinoids in leukemia and cellular processes (20 papers) and Acute Myeloid Leukemia Research (15 papers). Yingli Wu collaborates with scholars based in China, Thailand and United States. Yingli Wu's co-authors include Guoqiang Chen, Hanzhang Xu, Hu Lei, Chuanxu Liu, Feng‐Hou Gao, Wei‐Lie Xiao, Han‐Dong Sun, Weiwei Wang, Meng Zhao and Chunmin Ma and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yingli Wu

142 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingli Wu China 32 2.2k 541 516 327 278 145 3.2k
Stefano Tiziani United States 26 1.7k 0.8× 748 1.4× 299 0.6× 254 0.8× 280 1.0× 80 3.0k
Ramzi M. Mohammad United States 41 2.9k 1.3× 601 1.1× 1.2k 2.4× 319 1.0× 374 1.3× 154 4.8k
Li‐Shun Wang China 30 1.8k 0.8× 513 0.9× 487 0.9× 111 0.3× 243 0.9× 113 2.8k
Quansheng Zhou China 37 2.3k 1.0× 519 1.0× 640 1.2× 254 0.8× 871 3.1× 89 3.7k
Jifa Zhang China 27 1.6k 0.7× 297 0.5× 448 0.9× 114 0.3× 186 0.7× 98 2.6k
Feng Zhu China 40 2.6k 1.1× 639 1.2× 781 1.5× 102 0.3× 372 1.3× 122 4.1k
H. Dorota Halicka United States 34 2.4k 1.1× 652 1.2× 831 1.6× 108 0.3× 276 1.0× 68 3.4k
Francesco Facchiano Italy 38 2.0k 0.9× 738 1.4× 374 0.7× 163 0.5× 543 2.0× 96 4.0k
Kevin Harvey United States 33 1.5k 0.7× 429 0.8× 289 0.6× 141 0.4× 352 1.3× 74 3.1k

Countries citing papers authored by Yingli Wu

Since Specialization
Citations

This map shows the geographic impact of Yingli Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingli Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingli Wu more than expected).

Fields of papers citing papers by Yingli Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingli Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingli Wu. The network helps show where Yingli Wu may publish in the future.

Co-authorship network of co-authors of Yingli Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingli Wu. A scholar is included among the top collaborators of Yingli Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingli Wu. Yingli Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yingying, Gareth R. Williams, Yanyan Zhang, et al.. (2025). A photothermally triggered cascade bioreactor for cuproptosis and ferroptosis-driven cancer immunotherapy. Journal of Colloid and Interface Science. 699(Pt 1). 138100–138100. 2 indexed citations
2.
Qiu, Fang, Yuntong Li, Yingli Wu, et al.. (2024). Mapping and visualization of global research progress on deubiquitinases in ovarian cancer: a bibliometric analysis. Frontiers in Pharmacology. 15. 1445037–1445037.
3.
Zheng, Fang, et al.. (2024). Stellate ganglion block for visceral pain in elderly patients undergoing video-assisted thoracoscopic lung cancer surgery: a randomized, controlled trial. International Journal of Surgery. 110(11). 6996–7002. 4 indexed citations
4.
Yang, Yu, Yingli Wu, Xujin Gong, et al.. (2024). In Vitro and Circulation Kinetic Studies on π-π-stacked Poly (ɛ-caprolactone)-based Micelles Loaded with Olaparib. 2(1). 1–1–9. 1 indexed citations
5.
Sun, Yi, et al.. (2024). Targeting iron-metabolism:a potential therapeutic strategy for pulmonary fibrosis. Biomedicine & Pharmacotherapy. 172. 116270–116270. 16 indexed citations
6.
Zhang, Xingming, Li Yang, Yingying Wang, et al.. (2023). Anlotinib exerts an anti-T-cell acute lymphoblastic leukemia effect in vitro and in vivo. Cellular Signalling. 110. 110837–110837. 2 indexed citations
7.
Xiao, Xinhua, et al.. (2023). GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia. Cancer Cell International. 23(1). 302–302. 2 indexed citations
8.
Li, Na, Xiaochen Lu, Midie Xu, et al.. (2023). Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression. Nature Metabolism. 5(7). 1159–1173. 50 indexed citations
9.
Luo, Hao, et al.. (2022). Ubiquitin Specific Protease 2: Structure% Isoforms% Cellular Function% Related Diseases and Its Inhibitors. ONCOLOGIE. 24(1). 85–99. 5 indexed citations
10.
Wu, Yingli, Lian‐Lian Hong, Zhenan Ling, et al.. (2022). Golgi scaffold protein PAQR3 as a candidate suppressor of gastric cardia adenocarcinoma via regulating TGF‐β/Smad pathway. Journal of Clinical Laboratory Analysis. 36(9). e24617–e24617. 5 indexed citations
11.
Xiao, Xinhua, Yangyang Niu, Peihong Wang, et al.. (2022). TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma. Frontiers in Molecular Biosciences. 9. 647826–647826. 9 indexed citations
12.
Yang, Jun, Yuan Liu, Yu Zhang, et al.. (2021). PGE2-JNK signaling axis non-canonically promotes Gli activation by protecting Gli2 from ubiquitin-proteasomal degradation. Cell Death and Disease. 12(7). 707–707. 9 indexed citations
13.
Chen, Yun, Yingli Wu, Jie Cheng, et al.. (2021). Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations. Journal of Medicinal Chemistry. 64(19). 14664–14701. 22 indexed citations
14.
Song, Lili, et al.. (2019). Isobavachalcone reveals novel characteristics of methuosis-like cell death in leukemia cells. Chemico-Biological Interactions. 304. 131–138. 27 indexed citations
15.
Wu, Ke, Xiaoting Yu, Zhimin Huang, et al.. (2018). Targeting of PP2Cδ By a Small Molecule C23 Inhibits High Glucose-Induced Breast Cancer Progression In Vivo. Antioxidants and Redox Signaling. 30(17). 1983–1998. 12 indexed citations
16.
Yang, Zhongyin, Chen Li, Chao Yan, et al.. (2018). KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(1). 181–192. 64 indexed citations
17.
Liu, Zhen, et al.. (2016). Oridonin enhances the anticancer activity of NVP-BEZ235 against neuroblastoma cells in vitro and in vivo through autophagy. International Journal of Oncology. 49(2). 657–665. 13 indexed citations
18.
Yang, Li, Hu Lei, Wei Wei, et al.. (2015). Hsp90 Is a Novel Target Molecule of CDDO-Me in Inhibiting Proliferation of Ovarian Cancer Cells. PLoS ONE. 10(7). e0132337–e0132337. 27 indexed citations
19.
Zhang, Yue, Fujun Zhao, Lilan Chen, et al.. (2014). MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer. PubMed Central. 3 indexed citations
20.
Zhao, Shan, Chunmin Ma, Chuanxu Liu, et al.. (2012). Autophagy inhibition enhances isobavachalcone-induced cell death in multiple myeloma cells. International Journal of Molecular Medicine. 30(4). 939–944. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Tiziani Breakdown of academic impact, for papers by Ramzi M. Mohammad Breakdown of academic impact, for papers by Li‐Shun Wang Breakdown of academic impact, for papers by Quansheng Zhou Breakdown of academic impact, for papers by Jifa Zhang Breakdown of academic impact, for papers by Feng Zhu Breakdown of academic impact, for papers by H. Dorota Halicka Breakdown of academic impact, for papers by Francesco Facchiano Breakdown of academic impact, for papers by Kevin Harvey
Rankless by CCL
2026